Are head-to-head trials of biologics needed? The role of value of information methods in arthritis research.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Works matching IS 14620324 AND DT 2011 AND VI 50 AND IP suppl_4
Results: 17
1
2
Development of the Birmingham Rheumatoid Arthritis Model: past, present and future plans.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
3
Indirect and mixed treatment comparisons in arthritis research.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
4
The Sheffield rheumatoid arthritis health economic model.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
5
Effectiveness of biologics in rheumatology: improving the evidence base.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
6
An overview of models used in economic analyses of biologic therapies for arthritis—from current diversity to future consensus.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
7
Modelling the cost-effectiveness of biologic treatments for psoriatic arthritis.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
8
A clinician’s critique of rheumatoid arthritis health economic models.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
9
Are head-to-head trials of biologics needed? The role of value of information methods in arthritis research.
- Published in:
- Rheumatology, 2011, v. 50, n. suppl_4, p. iv19, doi. 10.1093/rheumatology/ker242
- By:
- Publication type:
- Article
10
Development of the Birmingham Rheumatoid Arthritis Model: past, present and future plans.
- Published in:
- Rheumatology, 2011, v. 50, n. suppl_4, p. iv32, doi. 10.1093/rheumatology/ker244
- By:
- Publication type:
- Article
11
Indirect and mixed treatment comparisons in arthritis research.
- Published in:
- Rheumatology, 2011, v. 50, n. suppl_4, p. iv5, doi. 10.1093/rheumatology/ker241
- By:
- Publication type:
- Article
12
The Sheffield rheumatoid arthritis health economic model.
- Published in:
- Rheumatology, 2011, v. 50, n. suppl_4, p. iv26, doi. 10.1093/rheumatology/ker243
- By:
- Publication type:
- Article
13
Use of biologic agents in rheumatoid arthritis: introduction.
- Published in:
- Rheumatology, 2011, v. 50, n. suppl_4, p. iv3, doi. 10.1093/rheumatology/ker239
- By:
- Publication type:
- Article
14
An overview of models used in economic analyses of biologic therapies for arthritis—from current diversity to future consensus.
- Published in:
- Rheumatology, 2011, v. 50, n. suppl_4, p. iv10, doi. 10.1093/rheumatology/ker240
- By:
- Publication type:
- Article
15
Modelling the cost-effectiveness of biologic treatments for psoriatic arthritis.
- Published in:
- Rheumatology, 2011, v. 50, n. suppl_4, p. iv39, doi. 10.1093/rheumatology/ker245
- By:
- Publication type:
- Article
16
A clinician’s critique of rheumatoid arthritis health economic models.
- Published in:
- Rheumatology, 2011, v. 50, n. suppl_4, p. iv48, doi. 10.1093/rheumatology/ker246
- By:
- Publication type:
- Article
17
Effectiveness of biologics in rheumatology: improving the evidence base.
- Published in:
- Rheumatology, 2011, v. 50, n. suppl_4, p. iv1, doi. 10.1093/rheumatology/ker238
- By:
- Publication type:
- Article